Trinseo (NYSE: TSE), the global materials company and manufacturer of plastics, latex binders and synthetic rubber, is seeing increased demand for its glass-filled CALIBRE™ 5000 Polycarbonate Resins for medical device applications. The medical device industry continues to grow globally. With the rising trend toward device portability and bedside care, Trinseo’s resins are being used as an alternative to metal and higher cost plastics.
The glass-filled CALIBRE™ 5000 Polycarbonate Resins series was developed specifically for medical device applications. The materials feature properties that are important to such applications including sterilization options, comprehensive ISO 10993 biocompatible test support data, robust lot traceability and a strict management of change process.
Trinseo’s glass-filled resins can be custom formulated to meet application needs with varying glass content of up to 30 percent. Combining stiffness, toughness, dimensional stability and biocompatibility, the resins can be used for devices ranging from hand-held surgical instruments, to diagnostic devices and patient monitor housings, and even wearable devices. Glass-filled polycarbonate can be used to replace metal parts or to down gauge existing plastic parts.
The CALIBRE™ family of products offers the advantages of processability and flexibility for creative design. These resins also enable the consolidation of parts through the molding process and potentially can reduce assembly costs.
Trinseo has a history of supporting the medical device industry and recently became ISO 13485:2016 certified to support the industry’s disciplined quality control and regulatory guidelines.
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding the timing of the proposed acquisition of the Arkema MMA and PMMA business (the "Acquisition"); estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities and cost synergies relating to the Acquisition, our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to, our failure to complete the Acquisition or meet the conditions to closing, including antitrust, works council and other regulatory approvals; the failure to obtain the financing necessary to fund the Acquisition and the impact of the substantial indebtedness to be incurred; costs related to the Acquisition; following the Acquisition, our ability to successfully integrate the acquired businesses, generate expected cost savings and synergies, maintain relationships with customers, retain key employees and profitably grow the business; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.